Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Study Group: Pathologists (US)(?)

Council Members in this Study Group: 824

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Request a survey with this Study Group







Leading Experts in this Study Group

Joseph Schappert, MD
Medical Director
Icon Central Laboratories, Inc.

Joseph Schappert, MD, is the Medical Director at ICON Laboratories, Inc. in New York. He is involved in innovative and state-of-art information technology, flow cytometric and molecular diagnostic solutions in support of clinical trials conducted worldwide. Previously, Dr. Schappert was the Vice Chair...

Robert Boorstein, MD, PhD
Director of Pathology
Bellevue Hospital Center

Robert Boorstein, MD, PhD, is the Director of Pathology at Bellevue Hospital and an Associate Professor in the Department of Pathology at New York University School of Medicine. He is also the Medical Director for Pathology and Laboratory Medicine of the South Manhattan Healthcare Network and Northern...

John Cochran, MD
Founder and Senior Pathologist
Chestatee Pathology Associates, PC

John Cochran, MD, is the Chief Executive Officer of Chestatee Pathology Associates, PC (Atlanta, GA). He is the Medical Director of two Atlanta-area hospital laboratories. Dr. Cochran has consulted on the following companies: Genzyme, ePocrates, Cerner, NextGen, AllScripts, GE Healthcare, Immucor, Beckman...

Jed Gorlin, MD
Transfusion Service Director
Hennepin County Medical Center

Jed Gorlin, MD, MBA, is the Medical Director of the Memorial Blood Center of Minnesota and an Associate Professor of Laboratory Medicine and Pediatrics at the University of Minnesota. Dr. Gorlin is also the Transfusion Services Director at Hennepin County Medical Center. His research includes the hematopoietic...

Jin Suh, MD
Assistant Clinical Professor of Medicine
New York- Presbyterian/Columbia University Medical Center

Jin Suh, MD, is an Assistant Clinical Professor of Medicine at the Columbia University College of Physicians and Surgeons. He is also an Associate Medical Director of the HIV-AIDS Program at St. Luke's-Roosevelt Hospital, New York. Dr. Suh is board certified in Internal Medicine and Infectious Disease....

GLG NewsSMAnalyses by this Study Group's Leading Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
DRUG VERSES FOOD-IMPORTANCE HOW MD CAN HELP THEIR PATIENT | 07-21-2008
Analysis of: Patients Curb Prescription Spending | online.wsj.com
Author: GLG Expert Contributor

TODAY MANY PATIENTS HAS DILEMA TO BUY FOOD OR DRUG               EFECTIVENESS OF GENERIC DRUG ALSO MAIL ORDER OR LOCAL PHARMACY COST

Novel molecules and diagnostic tests | 02-19-2008
Analysis of: Kidney Cancer Drug Linked to Higher Rate of Heart Problems | www.washingtonpost.com
Author: Joseph Schappert, MD, Medical Director , Icon Central Laboratories, Inc.

Diagnostic tools are availible to identify these adverse effects at an early stage in their clinical development. These tools should mitigate the seriousness of these adverse events.

A Possible Botox "Black Box" Warning Will Serve No Purpose | 02-18-2008
Analysis of: FDA Issues Warning About Botox Deaths | www.pharmalot.com
Author: GLG Expert Contributor

1) Dissemination of information on Botox related complications is important.  2) Lay press coverage of Botox related complications will likely transiently reduce Botox utilization. 3) A "black box" warning from the FDA will serve no useful purpose. 

Sysmex has potential to expand current penetration and open new market | 01-11-2008
Author: GLG Expert Contributor

Integrating conventional blood analysis with flow cytometry paves the way for penetration from the former routine testing market into the latter, specialized cancer testing market.  This platform has the potential to broaden penetration by offering more test capabilities onto an existing platform....

mTCR: a biomed black swan? | 01-09-2008
Author: GLG Expert Contributor

The holy grail of pharmacology is specificity, inventing drugs that faithfully reach their target but do not affect other cells.  Monoclonal antibodies have potential but have not yet reached that mark.  Monoclonal T cell receptors (mTCR) might succeed where all other drugs have failed.

View All GLG News by members of this Study Group

Most Common Company Types:

  • Academic Medical Center/Hospital or Clinic
  • Academic Institution*
  • Lab, Academic Medical Center
  • Laboratory, Independent
  • Office Based Private Practice or Clinic
  • Non-Academic Community Hospital or Clinic
  • Lab, Non-Academic/Community Hospital

Most Common Job Types:

  • Physician - Attending Physician
  • Director
  • Professor
  • Physician - Director
  • Research Scientist
  • Physician - Department Chair

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics


Generated at 2008-12-03T13:45:45.387